Haemodynamic Effect of Dexmedetomidine

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Haemodynamic Effects of Dexmedetomidine
Interventions
DRUG

Dexmedetomidine

1 mcg/kg over 10 minutes, followed by a maintenance infusion titrated to achieve desired clinical effect - Richmond Agitation Scale between 0 and (-) 3. Holter ECG recording before start of infusion and during infusion for 25 minutes.

Trial Locations (1)

80-214

Medical University of Gdansk, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER

NCT02566863 - Haemodynamic Effect of Dexmedetomidine | Biotech Hunter | Biotech Hunter